Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease-2 [PDF]
, 2011 Copyright information:Taken from "Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease"BMC Veterinary Research 2006;2 ...
Gerald Misinzo (72592) +6 more
core +1 more source
Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease-1 [PDF]
, 2011 Copyright information:Taken from "Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease"BMC Veterinary Research 2006;2 ...
Gerald Misinzo (72592) +6 more
core +1 more source
Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease-3 [PDF]
, 2011 Copyright information:Taken from "Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease"BMC Veterinary Research 2006;2 ...
Gerald Misinzo (72592) +6 more
core +1 more source
Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease-0 [PDF]
, 2011 Copyright information:Taken from "Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease"BMC Veterinary Research 2006;2 ...
Gerald Misinzo (72592) +6 more
core +1 more source
DETECTION OF TORQUE TENO SUS VIRUS (TTSUV) IN CLINICAL SPECIMENS OF PIGS WITH CLASSICAL SWINE FEVER, PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME, AND PORCINE CIRCOVIRUS 2 INFECTIONS [PDF]
Exploratory Animal and Medical Research, 2020 Torque teno sus viruses (TTSuVs) have never been implicated in the direct causation of any disease; however, their role as cofactors in the precipitation of certain disease conditions is gaining some support.
Vinutha Subramanyam +5 more
doaj
BMC Immunology, 2017 Background Porcine circovirus 2 (PCV2) is a small, non-enveloped DNA virus causing swine lymphocyte depletion and severe impact on the swine industry.
Ling-Chu Hung +2 more
doaj +1 more source
Porcine Circovirus Type 2 Pathogenicity Alters Host’s Central Tolerance for Propagation
Pathogens, 2020 Porcine circovirus type 2 (PCV2) infections and resulting diseases are a worldwide threat to pig production. PCV2 bears a uniqueness that allows for us to understand more about chronic infections and the immune system in general.
Xaver Sidler +4 more
doaj +1 more source
MOLECULAR AND PATHOLOGICAL STUDIES OF POST-WEANING MULTI-SYSTEMIC WASTING SYNDROME AMONG PIGLETS IN KERALA, INDIA [PDF]
Exploratory Animal and Medical Research, 2019 Post weaning multi systemic wasting syndrome (PMWS) is an economically important porcine viral associated diseases caused by porcine circovirus 2(PCV2) in weaned piglets worldwide. Recently, the presence of PCV2 was reported in pig population of Kerala.
R. Sairam +6 more
doaj
Development and validation of TaqMan probe-based real-time polymerase chain reaction for detection of Porcine Circovirus 2 [PDF]
Journal of Veterinary and Animal Sciences, 2023 Pigs are under constant threat from many infectious diseases and post-weaning multisystemic syndrome (PWMS) is one among them. The syndrome is caused by the Porcine Circovirus 2 (PCV2) which belongs to the Circoviridae family.
S. Shashank +10 more
doaj +1 more source
PCV2 but not PCV2 genome or PCV2-encoded components affects CSFV replication in PK15-CSFV cells. [PDF]
, 2015 Cells were inoculated with PCV2 at MOI of 1 or 10 and pretreated with inactivated PCV2, genomic DNA of PCV2 or PCV2-encoded components. (A and C) Percentage of TUNEL-positive cells.
Boli Hu (750407) +9 more
core +1 more source